Digital platform for pharmaceutical surplus management

Restoring value to unused medicines,
with a compliant and traceable supply chain

ReVita Circle is the first European platform that enables pharmaceutical companies and distributors to redistribute unused batches in a compliant and verified manner to authorized healthcare facilities. More value, less waste, full compliance with GDP guidelines.

We reduce waste and disposal costs, enable a transparent supply chain and support access to essential medicines, without ever physically handling products.

+€5 Bln
medicines disposed of each year in Europe*
40%
of surplus can be safely recovered
100%
Digital intermediation, without direct product handling
Discover the platform
Compliant with regulations
EU GDP
AIFA
EMA
Companies & Distributors
Unsold batches
ReVita Circle
Verified matching
Accredited Facilities & NGOs
Compliant processeswith European GDP guidelines
Circular impactwaste and CO₂ reduction
Automatic matchingbased on AI and compliance criteria
Scroll to discover
The Global Challenge

Huge waste. Critical need. A gap we can close.

Every year millions of compliant pharmaceutical packages are disposed of due to lack of alternative channels, while in many areas of the world healthcare facilities lack access to essential medicines. ReVita Circle connects these two worlds in a compliant, verified and traceable way.

≈ €5 billion
estimated value of medicines disposed of each year in Europe*
~ 2 billion
people without regular access to essential medicines*
40%
of waste potentially avoidable with circular management

Surplus and disposal

Pharmaceutical companies and distributors produce excess batches to ensure supply continuity. However, in the absence of alternative channels and compliant digital solutions, many products end up incinerated with significant economic and environmental costs.

Unequal access to care

In many areas of the world, healthcare facilities and humanitarian organizations struggle to source basic medicines. This gap, aggravated by inefficiencies in global distribution, represents one of the main health challenges recognized by the WHO.

*Sources: AIFA, WHO (World Health Organization), OECD - estimates on pharmaceutical waste and access to essential medicines.

Our solution

Technology and compliance at the service of global health

ReVita Circle is a B2B digital intermediation platform that facilitates the compliant redistribution of unused pharmaceutical batches, connecting companies and authorized healthcare facilities. We manage matching, verification, documentation and traceability digital intermediation, without direct product handling.

Security and compliance

We operate as digital intermediaries: KYB controls, licenses, VIES, verification of parties involved and end-to-end documentary traceability, without physical product handling.

Intelligent matching

Matching engine that cross-references active ingredient/ATC, country of origin/destination, import/export requirements, residual shelf-life, storage conditions and quantities, prioritizing urgent cases.

Network and global impact

Access to accredited healthcare organizations and logistics partners compliant with good distribution practices, for international redistributions in compliance with local regulations.

Dashboard & reporting

Operational and ESG KPIs: recovered batches, packages, residual shelf-life, avoided disposal costs and estimated CO₂. Exportable reports for audits and sustainability reports.

Verified partners

KYB onboarding with checks on VAT (VIES), licenses and documentation; references and post-transaction rating to ensure transparency and reliability.

Digital workflow

From registration to proof of delivery: batch publication, due diligence, match proposal, agreement, export/import documents, logistics and audit trail.

Ready to make a difference?

Talk to us: we verify requirements, use cases and compliant flows for your company.

The process

5 steps towards concrete impact

A simple and compliant operational flow that digitalizes matching, verification, documentation and traceability digital intermediation, without direct product handling.

01

Registration and verification

Business onboarding with KYB checks: we verify identity, VAT (VIES), licenses and references. Automated document verification with human control for sensitive cases.

  • KYB & VIES
  • Licenses/authorizations
  • Domain and references verification
02

Batch publication

Companies insert surplus with structured metadata for traceability: name, active ingredient/ATC, batch/lot and expiration, quantity, country of origin and storage conditions.

  • Batch/lot and expiration
  • Storage conditions
  • Country of origin and quantity
03

Automatic matching

The matching engine cross-references supply and demand based on active ingredient/ATC, import/export requirements, residual shelf-life, temperature, volumes and operational priorities.

  • Compliance criteria
  • Expiration/urgency priority
  • Logistics suggestions
04

Agreement and logistics

The parties finalize the agreement on the platform. Transport is carried out by certified logistics operators chosen by the parties; we provide documentary traceability, tracking and POD.

  • Export/import documents
  • Tracking and POD
  • Cold chain where required
05

Impact and reporting

Dashboard with operational and ESG KPIs: recovered batches, packages, residual shelf-life, avoided disposal costs and estimated CO₂. Exportable reports for audits and sustainability reports.

  • Live dashboard
  • Exportable ESG reports
  • End-to-end audit trail
Priority
Match on deadlines and urgencies
Reliability
High availability cloud infrastructure
Traceability
Documents and events always on record
Metrics and transparency

Measurable impact, transparent methodology

ReVita Circle shows operational and ESG KPIs based on verified data: recovered batches, residual shelf-life, avoided disposal costs and estimated CO₂ through standard factors (GHG Protocol). Metrics become public when available and are accompanied by methodological notes.

Live KPI
Waste reduction
Recovered batches and packages compared to disposal, with detail by active ingredient and residual shelf-life.
Transparent methodology
DDD/WHO
Access to care
Estimate of patients potentially reached based on DDD/clinical guidelines for each product (WHO).
WHO methodology
GHG Protocol
Avoided emissions
Estimated CO₂ compared to incineration/alternative transport, calculated with standard factors (GHG Protocol).
Verifiable standard factors
KYB & VIES
Verified partners
Companies and organizations accredited through KYB checks, VIES and authorization documentation; post-transaction rating.
Document controls

Sources and method: WHO (Defined Daily Dose) for patient estimate; GHG Protocol for avoided CO₂; internal benchmarks and records for recovered batches. Metrics are published only after document verification.

Become a Founding Partner

Program dedicated to pharmaceutical companies and healthcare institutions who want to contribute to defining the new European standard for compliant pharmaceutical surplus redistribution.

  • Priority access to the platform
  • Involvement in the validation committee for standards and processes
  • Personalized ESG reports and dedicated audit trail
  • Early access to advanced features
  • Preferential economic conditions
  • Official "Founding Partner" badge